Trials / Completed
CompletedNCT03112382
Effect of SLC30A8 rs13266634 Genetic Polymorphism on Zinc Supplementation and Glycemic Control in Egyptian Patients With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 20 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
Study whether SLC30A8 rs13266634 polymorphism is associated with type 2 diabetes mellitus (T2DM) susceptibility in Egyptian patients and study effect of Zn supplementation on glycemic control in patients with type 2 diabetes
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | zinc supplement plus vitamin A and E | |
| DRUG | vitamin A and E |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2017-05-01
- Completion
- 2017-05-01
- First posted
- 2017-04-13
- Last updated
- 2017-08-08
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03112382. Inclusion in this directory is not an endorsement.